Noble Wealth Management PBC’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
ATO
HCM
AAMU
FWCM
AAIS
Noble Wealth Management PBC's ABBV Position: Q2 2026 in Review
Noble Wealth Management PBC opened a new position in AbbVie (ABBV) in Q2 2026: 7 shares worth $1.76K. The stake represents ﹤0.01% of the portfolio and ranks #596 among its holdings. This is a return to the name: Noble Wealth Management PBC previously reported a position in ABBV as recently as Q4 2025.
Noble Wealth Management PBC first reported a position in ABBV in Q4 2024 and has held it in 5 quarters since. The position peaked at $9.96K in Q3 2025. 1,529 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Noble Wealth Management PBC held 7 shares of AbbVie worth $1.76K as of Q2 2026.
- AbbVie was a new Noble Wealth Management PBC position in Q2 2026.
- AbbVie made up ﹤0.01% of Noble Wealth Management PBC's portfolio in Q2 2026, its #596 holding.
- Noble Wealth Management PBC first reported a position in AbbVie in Q4 2024 and has held it in 5 quarters since.
- Noble Wealth Management PBC's AbbVie position peaked at $9.96K in Q3 2025.
- 1,529 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Noble Wealth Management PBC's 13F filing for Q2 2026, filed 1 Jul 2026.